Loading…
MODERATESouth China Morning PostUnverifiedUnpublished
Fact-check: Multiple recent X posts from finance accounts like @WorksBamboo and @byul_finance confirm XtalPi's announcement of expected first annual profit of at least 100 million yuan in 2025 on 193% revenue growth, reversing a 1.52 billion yuan loss, with direct links to the SCMP article and matching details. The story is corroborated by web reports from SCMP and other outlets, showing real-time consistency and no contradictions.
Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump
xtalpichinahong-kongartificial-intelligencedrug-researchbiotechfinancial-resultsshenzhen
Chinese AI-powered drug researcher XtalPi Holdings has announced it expects to achieve its first annual profit in 2025, projecting a net profit of at least 100 million yuan compared to a net loss of approximately 1.5 billion yuan in 2024. The Shenzhen-based company attributed the turnaround to a 193% jump in revenue. The announcement was made via a filing with the Hong Kong Stock Exchange.